Area of research
Cardiology and Cardiovascular Medicine · Cancer Research
Research interest
Research interests include MicroRNA in disease regulation, Cardiac electrophysiology and arrhythmias, Cardiovascular Function and Risk Factors, and Circular RNAs in diseases.
Right Heart Remodeling and Outcomes in Patients With Tricuspid Regurgitation
Mitral annulus disjunction in consecutive patients undergoing cardiovascular magnetic resonance: Where is the boundary between normality and disease?
High-resolution DNA methylation changes reveal biomarkers of heart failure with preserved ejection fraction versus reduced ejection fraction
Immunometabolic mechanisms of heart failure with preserved ejection fraction
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca <sup>2+</sup> -ATPase Expression in Cardiomyocytes
Dissecting the transcriptome in cardiovascular disease
rs41291957 controls miR‐143 and miR‐145 expression and impacts coronary artery disease risk
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease
Characterization of Myocardial Injury in Patients With COVID-19
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
Correction to: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept
Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart
Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives
ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
MicroRNA-133 Modulates the β <sub>1</sub> -Adrenergic Receptor Transduction Cascade
Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress
Novel therapeutic strategies for cardioprotection
Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
Akt regulates L-type Ca2+ channel activity by modulating Cavα1 protein stability